Loading...

GRAIL, Inc.

GRAL•NASDAQ
Healthcare
Medical - Diagnostics & Research
$54.42
$3.77(7.44%)
U.S. Market opens in 23h 5m

GRAIL, Inc. (GRAL) Stock Overview

Explore GRAIL, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.2B
P/E Ratio-5.47
EPS (TTM)$-11.11
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$69.54
3 Months$101.70
1 Year Target$122.87

GRAL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GRAIL, Inc. (GRAL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $122.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.47 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
7.44%
5-Day Change
6.29%
1-Month Change
11.86%
3-Month Change
-48.12%
6-Month Change
-39.12%
Year-to-Date (YTD) Change
-36.42%
1-Year Change
44.39%
3-Year Change
298.39%
5-Year Change
298.39%
All-Time (Max) Change
298.39%

Contact Information

https://grail.com
833-694-2553
1525 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

1,000 Employees
IPO DateJun 12, 2024
CountryUS
Actively Trading

Frequently Asked Questions